查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1835417

全球退伍軍人菌檢測市場預測（2025-2032 年），按檢測方法、產品類型、應用、最終用戶和分銷管道分類

Legionella Testing Market by Test Method, Product Type, Application, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年退伍軍人菌檢測市場規模將成長至 7.8264 億美元，複合年成長率為 9.24%。

主要市場統計數據
基準年2024年 3.8586億美元
預計2025年 4.2231億美元
預測年份：2032年 7.8264億美元
複合年成長率（%） 9.24%

本執行摘要概述了塑造退伍軍人菌偵測和控制格局的關鍵發展。儘管公共衛生官員和設施管理人員長期以來一直將退伍軍人菌監測放在首位，但近期的技術進步、監管審查的加強以及不斷變化的業務需求正在共同重塑組織檢測和降低風險的方式。實驗室科學、設施營運、水務公司和商業房地產領域的相關人員越來越需要切實可行的情報，以彌合實驗室績效與現場實施之間的差距。

下面，我們將提煉出方法論、供應鏈動態、監管壓力點和最終用戶期望方面最顯著的變化。我們重點關注關稅調整的影響，探討測試方法、產品類型、應用、最終用戶和分銷管道之間的細分差異，並提供區域觀點以指導策略規劃。自始至終，我們專注於將測試數據轉化為強大的管理方案，增強採購彈性，並利用創新來加快成果落地速度，增強決策信心。

本介紹作為後續章節的框架，提供分析深度和實用建議，旨在為領導者提供豐富的背景觀點，以幫助做出投資決策、供應商參與以及實驗室和現場工作流程的改進。

診斷技術的快速進步、法規的不斷加強以及供應鏈的不斷發展如何重塑實驗室實踐、採購和營運整合

過去幾年發生了一系列變革性變化，重新定義了退伍軍人菌檢測的構想、實施和操作方式。分子診斷和生物感測器平台的技術進步縮短了獲得結果的時間，並將檢測從集中式實驗室擴展到靈活的現場檢測模式。同時，樣品濃度、自動化系統和試劑品質的改進提高了可重複性，減少了人工差異，並使監測項目更加一致。

許多司法管轄區的法律規範正在收緊，提高了對文件記錄、標準化驗證和可追溯性的期望。這些監管收緊措施與相關人員對水資源管理透明度日益成長的需求相吻合，迫使設施管理人員和水務公司將測試結果整合到建築自動化和風險管理儀錶板中。同時，供應鏈日益複雜，以及諸如承包監控訂閱和第三方實驗室合作等新型服務模式的出現，正在改變採購行為和供應商關係。

綜上所述，這些變化正在創造一個新格局：速度、可靠性和互通性與分析靈敏度同等重要。領導者若能將新技術投資與完善的檢驗方案和清晰的營運路徑結合，將更有能力將診斷技術的進步轉化為輻射暴露風險的顯著降低。

2025 年關稅變化如何改變整個退伍軍人菌檢測生態系統的供應鏈、籌資策略和成本管理方法

美國將在2025年實施的關稅將對整個軍團退伍軍人菌檢測生態系統產生複雜的連鎖反應，影響製造商、經銷商、檢測實驗室和最終用戶。對於依賴全球採購精密零件的儀器製造商而言，進口成本的上升促使他們重新評估供應鏈策略，包括遷移組裝組裝、實現供應商多元化以及以模組化為重點的重新設計，以減輕關稅的影響。這些策略調整將影響交貨前置作業時間、產品供應以及實驗室管理人員和設施營運商的長期資本規劃。

試劑和耗材通常是檢測項目的經常性支出，尤其容易受到成本變動的影響。因此，實驗室經理和採購團隊正在審查庫存政策，評估替代試劑的化學成分，並協商長期供應協議以穩定單位成本。同時，服務供應商和合約實驗室也面臨決策：是自行承擔成本、將成本轉嫁給客戶，還是最佳化工作流程以在維持交付和品質標準的同時保護淨利率。

重要的是，關稅壓力正在加速兩大應對措施。首先，企業重新重視國內生產和本地供應商開發，以減少跨國政策波動帶來的影響。其次，企業越來越重視供應商的透明度和韌性，並將其作為採購標準，優先考慮能夠提供試劑批次間等效性檢驗、本地技術支援以及零件短缺緊急時應對計畫等服務的合作夥伴。這些轉變正在重塑競爭動態，並使負責退伍軍人菌監測的營業單位的採購決策變得更加複雜。

全面的細分觀點，將分析方法、產品系列、應用程式、最終用戶和分銷管道與您的業務需求相結合

了解市場區隔對於設計滿足營運需求和監管期望的測試策略至關重要。在考慮測試方法時，相關人員必須考慮生物感測器平台、培養方法、免疫測量和聚合酵素鏈鎖反應) 等技術之間的權衡，每種技術都提供不同的操作特性。培養方法包括過濾過濾和傳統瓊脂培養，它們為樣品處理和菌落計數提供不同的工作流程。 ELISA 和橫向流動化驗等免疫檢測工具提供可用於高頻監測的快速篩檢功能。同時，聚合酵素鏈鎖反應方法（包括即時PCR和傳統 PCR）提供高度敏感的分子檢測，對設備和解釋的要求各不相同。生物感測器技術在現場監測中越來越受歡迎，其中速度和易用性是優先考慮的因素。

產品類型影響採購和實驗室設計。設備選擇範圍廣泛，從自動化系統到手動系統，自動化系統提供高通量和一致性，而手動系統則為小批量操作提供成本彈性。套件、試劑和耗材構成了日常檢測活動的基礎。主要試劑類別包括抗體、培養基和DNA聚合酵素，所有這些產品都必須符合嚴格的品質和批次間一致性標準。從第三方實驗室分析到控制監控項目等服務，為那些傾向於外包技術執行並專注於糾正措施的營業單位提供了替代途徑。

退伍軍人菌檢測應用因具體情況而異，但通常分為環境監測、設施管理和水處理三類。每種應用都有其獨特的樣本矩陣、結果用例和風險接受度，因此需要量身定做的方法來選擇和驗證策略。最終用戶包括商業建築、醫院、研究機構和水務公司，每個用戶都有其獨特的營運限制、合規義務和相關人員期望。分銷管道的選擇——直銷、分銷商或線上——決定了產品和支援服務的獲取途徑，從而影響前置作業時間、技術服務可用性和採購複雜性。整合這些細分維度可以實現有針對性的採購、最佳化工作流程，並更好地將分析能力與現場風險緩解措施結合。

區域動態和監管差異影響全球市場中退伍軍人菌監測計畫的技術採用、服務模式和擴充性

區域動態對偵測專案的建構方式、技術的優先順序以及服務模式的演變有重大影響。在美洲，監管重點和公司治理標準正在推動對檢驗的敏捷方法、整合資料平台以及可跨多站點產品組合擴展的服務夥伴關係關係的需求。該地區的市場參與企業通常優先考慮與建築管理系統的互通性和集中式彙報，以支援企業範圍內的風險監控。

歐洲、中東和非洲 歐洲、中東和非洲的監管和基礎設施環境各不相同，導致各國採用模式各異。一些國家實施嚴格的水安全計劃和規定的檢測通訊協定，而其他國家則強調能力建設和諮詢框架。這種多樣性為技術提供者創造了機會，他們可以提供模組化解決方案，既適用於嚴格監管的醫院環境，也適用於更廣泛的市政供水系統。該地區也積極關注永續性和資源效率，這影響著採樣策略和設備選擇。

亞太地區的特點是基礎設施快速發展，日益重視公共衛生韌性，並不斷擴大實驗室現代化的投資。該地區的營業單位和大型商業開發商擴大採用自動化系統和分子診斷技術，以滿足日益嚴格的標準和客戶期望。在所有地區，本地製造能力、監管合規性以及技術服務網路的可近性仍然是決定採用檢測方法和擴大監測項目可行性的關鍵因素。

競爭動態的考量顯示技術創新、品質系統和服務整合決定了市場定位和採用軌跡

退伍軍人菌檢測領域的競爭態勢將由技術創新、服務差異化和供應鏈韌性共同塑造。大型製造商持續投資快速分子檢測、自動化和整合分析技術，而專業供應商則專注於現場生物感測器和高度自動化的培養工作站等細分領域能力。檢測開發商、儀器製造商和服務實驗室之間的策略夥伴關係日益普遍，從而能夠提供包含硬體、耗材、驗證支援和資料管理的捆綁式服務。

此外，擁有強大品管系統和透明批次驗證流程的公司能夠贏得實驗室主任和設施經理的信任。服務型公司憑藉著靈活的合約模式、託管監控程序以及為多站點客戶快速擴展現場營運的能力脫穎而出。從商業性角度來看，將與通路合作夥伴的直接交易與數位商務結合的分銷策略有助於加快部署速度並提供在地化支援。

圍繞檢測化學和生物感測器架構的智慧財產權持續影響著競爭定位，而對監管申報和現場檢驗研究的投資仍然是進入市場的重要障礙。那些將研發與實際用戶需求相結合的公司，例如精簡的工作流程、最低限度的培訓要求以及清晰的解讀指南，最有可能贏得中心化實驗室和分散式設施團隊的青睞。最終，市場會青睞那些集卓越技術、營運支援和彈性供應鏈於一體的公司。

實驗室管理人員、採購團隊和設施負責人可以實施的可行策略和營運措施，以提高測試效率和彈性

產業領導者應採取多管齊下的策略，在快速診斷投資與嚴格驗證和採購彈性之間取得平衡。首先，優先進行驗證研究，將檢測效能與營運決策閾值直接關聯，確保所選檢測方法適用於設施中遇到的特定樣本基質和用例場景。此外，應進行現場試驗，以評估易用性、維護需求和下游資料整合要求，作為實驗室驗證的補充。

第二，將彈性標準納入採購流程，加強供應商關係。強制要求試劑等效性、替代採購計劃和本地技術支援的透明度。在可行的情況下，實現供應商組合多元化，以減少單一來源中斷的風險，並評估長期契約，以應對政策變化導致的價格波動。第三，投資於員工能力和程序標準化，以確保將檢測結果轉化為糾正措施。訓練計畫、能力評估和清晰的升級路徑可以減少解讀的差異性，並縮短反應時間。

最後，將檢測結果整合到更廣泛的水安全和設施管理系統中，將數據與預防管治連結起來。建立明確的資料所有權治理機制、觸發改進的閾值，以及納入新科學證據和監管更新的定期審查流程。將技術嚴謹性與供應鏈前瞻性和營運整合相結合，可以幫助組織增強韌性，更有效地降低退伍軍人菌暴露風險。

採用穩健的混合方法研究途徑，結合相關人員訪談、實驗室檢驗評審和供應鏈映射，提供可行的建議

基礎研究採用混合方法，旨在捕捉技術性能屬性和營運實際情況。主要研究包括對實驗室主任、設施經理、營業單位代表和監管相關人員的結構化訪談，以收集關於方法偏好、採購限制和驗證期望的定性見解。這些相關人員的觀點輔以對實驗室工作流程和現場採樣通訊協定的觀察性審查，以在實際實踐中得出結論。

二次研究利用同行評審文獻、監管指南文件和技術白皮書，繪製方法能力、性能特徵和合規性促進因素圖譜。檢驗了實驗室驗證研究，以評估培養、免疫測量、分子和生物感測器方法的出結果時間、靈敏度和操作要求。供應鏈分析評估了組件採購路徑、經銷商網路和服務模式配置，以確定彈性因素和潛在瓶頸。

分析步驟包括技術性能摘要和供應鏈映射，以交叉驗證定性研究結果，並將其摘要為可行的建議。在相關情況下，情境分析檢驗了採購中斷和監管變化的影響，提供了策略選擇，但並未進行數值預測。這種調查方法確保研究結果既反映了測試表現的科學性，也反映了在不同作戰情況下實施的實際限制。

主要調查方法的綜合，強調了方法的嚴謹性、採購的彈性和營運的整合如何將診斷轉化為有效的暴露緩解。

總而言之，退伍軍人菌檢測生態系統正處於技術能力、監管期望和採購現實交匯的曲折點。分子診斷和生物感測器平台的進步提供了更快、更靈活的檢測方案，但價值鏈依賴嚴格的驗證、營運整合和可靠的供應鏈。與關稅相關的變化凸顯了供應商透明度和國內韌性的重要性，影響籌資策略，並促使各組織重新評估其庫存和採購政策。

細分分析表明，分析方法的選擇必須以目的為主導。基於培養的方法仍然是許多合規框架的核心，而免疫測量和生物感測器則提供快速篩檢能力，PCR技術則提供適合特定調查場景的分子靈敏度。產品選擇、應用環境、最終用戶限制和分銷管道進一步決定了可行性和有效性。地區動態加劇了複雜性，因此需要適應性的產品，以尊重監管多樣性和技術能力。

對於希望加強退伍軍人菌計畫的領導者來說，未來的道路是嚴謹的調查方法、彈性採購、強大的員工隊伍以及數據主導的管治的結合。透過使投資與業務需求保持一致，並強調檢驗等效性和供應商的連續性，組織可以將診斷方面的進步轉化為持續降低暴露風險並改善公共衛生結果。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 擴展遠端物聯網水質監測系統，用於大型設施中的退伍軍人菌即時檢測
  • 引入數位 PCR 檢測以提高退伍軍人菌檢測實驗室的靈敏度和速度
  • 整合人工智慧驅動的預測分析，主動評估建築水系統中退伍軍人菌的風險
  • 根據最新的國際水安全指南，對退伍軍人菌進行強制性常規檢測的監管執行
  • 開發攜帶式快速免疫檢測裝置，用於現場退伍軍人菌篩檢，以減少對實驗室的依賴
  • 實施集中式資料平台，用於跨多個站點的退伍軍人菌檢測結果，以便更輕鬆地追蹤合規性
  • 水處理公司和檢測實驗室合作夥伴提供端到端退伍軍人菌管理解決方案

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

第8章退伍軍人菌檢測市場（依檢測方法）

  • 生物感測器
  • 培養方法
    • 薄膜過濾培養
    • 常規瓊脂培養
  • 免疫檢測
    • ELISA方法
    • 橫向流動化驗
  • PCR方法
    • 即時PCR
    • 常規PCR方法

第9章退伍軍人菌檢測市場（依產品類型）

  • 裝置
    • 自動化系統
    • 手動系統
  • 套件
  • 試劑和耗材
    • 抗體
    • 培養基
    • DNA聚合酵素
  • 服務

第10章退伍軍人菌檢測市場（依應用）

  • 環境監測
  • 設施管理
  • 水處理

第 11 章退伍軍人菌檢測市場（依最終用戶）

  • 商業大廈
  • 醫院
  • 研究所
  • 供水業務

第 12 章退伍軍人菌檢測市場（依通路）

  • 直銷
  • 經銷商
  • 線上

第13章退伍軍人菌檢測市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第 14 章退伍軍人菌檢測市場：依類別

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 15 章。按國家/地區分類的退伍軍人菌檢測市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Eurofins Scientific SE
    • SGS SA
    • ALS Limited
    • Intertek Group plc
    • Bureau Veritas SA
    • TUV SUD AG
    • NSF International
    • Underwriters Laboratories LLC
    • Pace Analytical Services, LLC
    • Charles River Laboratories International, Inc.
Product Code: MRR-43470FC6086E

The Legionella Testing Market is projected to grow by USD 782.64 million at a CAGR of 9.24% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 385.86 million
Estimated Year [2025] USD 422.31 million
Forecast Year [2032] USD 782.64 million
CAGR (%) 9.24%

This executive summary synthesizes the critical developments shaping the landscape of Legionella testing and control. While public health authorities and facility managers have long prioritized Legionella surveillance, recent technological advances, heightened regulatory scrutiny, and evolving operational demands are converging to reshape how organizations detect and mitigate risk. Stakeholders across laboratory science, facility operations, water utilities, and commercial real estate increasingly require actionable intelligence that bridges laboratory performance with on-the-ground implementation.

The narrative that follows distills the most salient shifts in methodologies, supply chain dynamics, regulatory pressure points, and end-user expectations. It highlights the implications of tariff adjustments, examines segmentation nuances across test methods, product types, applications, end users, and distribution channels, and provides regional perspectives to inform strategic planning. Throughout, emphasis is placed on operationalizing test data into robust control programs, strengthening procurement resilience, and leveraging innovation to reduce time-to-result and enhance confidence in decision-making.

This introduction frames the subsequent sections, which collectively deliver both analytic depth and pragmatic recommendations. The intent is to equip leaders with context-rich perspectives that support investment decisions, supplier engagement, and improvements to laboratory and field workflows.

How rapid diagnostic advances, regulatory tightening, and supply chain evolution are collectively reshaping testing practices, procurement, and operational integration

The past several years have witnessed a set of transformative shifts that are redefining how Legionella testing is conceived, executed, and translated into action. Technological progress in molecular diagnostics and biosensor platforms has compressed time-to-result and expanded the locus of testing beyond centralized laboratories into field-adaptable formats. Concurrently, improvements in sample concentration, automated systems, and reagent quality are enhancing reproducibility and reducing manual variability, enabling more consistent surveillance programs.

Regulatory frameworks are tightening in many jurisdictions, prompting greater documentation, standardized validation, and expectations for traceability. This regulatory tightening operates alongside growing stakeholder demand for transparency in water management, driving facility managers and water utilities to integrate testing outputs with building automation and risk management dashboards. At the same time, supply chain complexity and the emergence of novel service models, such as turnkey monitoring subscriptions and third-party laboratory partnerships, are altering procurement behavior and vendor relationships.

Taken together, these shifts are creating a landscape where speed, reliability, and interoperability matter as much as analytical sensitivity. Leaders who align investments in new technology with robust validation protocols and clear operational pathways will be better positioned to convert diagnostic advances into measurable reductions in exposure risk.

Assessment of how tariff changes in 2025 have altered supply chains, procurement strategies, and cost-management approaches across the Legionella testing ecosystem

The introduction of tariffs in the United States during 2025 has generated a complex ripple effect across the Legionella testing ecosystem, affecting manufacturers, distributors, laboratories, and end users. For equipment makers that rely on global sourcing for precision components, increased import costs have incentivized a reassessment of supply chain strategies, including relocation of assembly, diversification of suppliers, and redesigns that emphasize modularity to mitigate tariff exposure. These strategic adjustments carry implications for lead times, product availability, and long-term capital planning for laboratory managers and facility operators.

Reagents and consumables, which often represent recurring expenditure for testing programs, are particularly sensitive to cost shifts. Laboratory directors and procurement teams are therefore reassessing inventory policies, evaluating alternative reagent chemistries, and negotiating longer-term supply agreements to stabilize unit costs. In parallel, service providers and contract laboratories face decisions about absorbing costs, passing them through to clients, or optimizing workflows to preserve margins while maintaining turnaround times and quality standards.

Importantly, tariff-induced pressures are accelerating two broader responses. First, there is a renewed emphasis on domestic manufacturing and local supplier development to reduce exposure to cross-border policy volatility. Second, organizations are increasingly valuing supplier transparency and resilience as procurement criteria, prioritizing partners that can offer validated equivalence across reagent lots, local technical support, and contingency plans for component shortages. These shifts are reshaping competitive dynamics and complicating procurement decisions for entities responsible for Legionella surveillance.

Comprehensive segmentation perspectives that align analytical methods, product portfolios, applications, end users, and distribution pathways with operational needs

Understanding market segmentation is central to designing testing strategies that match operational needs and regulatory expectations. When considering test methods, stakeholders must weigh trade-offs among biosensor platforms, culture methods, immunoassays, and polymerase chain reaction techniques, each offering distinct operational profiles. Culture methods remain foundational for regulatory compliance in many contexts and include both membrane filtration culture and traditional agar culture approaches that differ in sample processing and colony enumeration workflows. Immunoassay tools such as ELISA and lateral flow assays offer rapid screening capabilities that can be useful for high-frequency monitoring, whereas polymerase chain reaction approaches, which encompass real-time PCR and traditional PCR, provide sensitive molecular detection with varying requirements for instrumentation and interpretation. Biosensor technologies are gaining traction for on-site monitoring where speed and ease of use are prioritized.

Product type influences procurement and laboratory design. Equipment choices span automated and manual systems, with automation delivering throughput and consistency while manual systems provide cost flexibility for low-volume operations. Kits, reagents, and consumables form the backbone of daily testing activity; key reagent categories include antibodies, culture media, and DNA polymerases, all of which must meet rigorous quality and lot-to-lot consistency standards. Services-ranging from third-party laboratory analysis to managed monitoring programs-offer alternative pathways for entities that prefer to outsource technical execution and focus on corrective actions.

Applications for Legionella testing vary by context and are commonly grouped into environmental monitoring, facility management, and water treatment. Each application carries unique sample matrices, result-use cases, and risk tolerances, necessitating method selection and validation strategies tailored to the specific purpose. End users include commercial buildings, hospitals, research institutes, and water utilities, with each category presenting distinctive operational constraints, compliance obligations, and stakeholder expectations. Distribution channel choices-direct sales, distributors, and online-shape access to products and support services, affecting lead times, technical service availability, and procurement complexity. Integrating these segmentation dimensions enables targeted procurement, optimized workflows, and stronger alignment between analytical capability and on-site risk mitigation.

Regional dynamics and regulatory variations that influence technology adoption, service models, and the scalability of Legionella monitoring programs across global markets

Regional dynamics exert a strong influence on how testing programs are structured, which technologies are prioritized, and how service models evolve. In the Americas, regulatory attention and corporate governance standards are driving demand for validated rapid methods, integrated data platforms, and service partnerships that can scale across multi-site portfolios. Market participants in this region often emphasize interoperability with building management systems and centralized reporting to support enterprise-wide risk oversight.

Europe, the Middle East & Africa present a heterogeneous regulatory and infrastructural environment where adoption patterns vary across jurisdictions. Some countries implement stringent water safety plans and prescriptive testing protocols, while others emphasize capacity building and advisory frameworks. This diversity creates opportunities for technology providers that can offer modular solutions adaptable to both highly regulated hospital settings and broader municipal water systems. The region also demonstrates active interest in sustainability and resource efficiency, which influences sampling strategies and equipment selection.

Asia-Pacific features rapid infrastructure development, a rising focus on public health resilience, and growing investment in laboratory modernization. Water utilities and large commercial developers in the region are increasingly adopting automated systems and molecular diagnostics to meet tightening standards and customer expectations. Across all regions, local manufacturing capability, regulatory alignment, and access to technical service networks remain critical determinants of method adoption and the feasibility of scaling monitoring programs.

Insights into competitive dynamics showing how innovation, quality systems, and service integration determine market positioning and adoption trajectories

Competitive dynamics in the Legionella testing space are shaped by a combination of technological innovation, service differentiation, and supply chain resilience. Leading manufacturers continue to invest in rapid molecular assays, automation, and integrated analytics, while specialized providers focus on niche capabilities such as on-site biosensors or highly automated culture workstations. Strategic partnerships between assay developers, instrument manufacturers, and service laboratories are increasingly common, enabling bundled offerings that combine hardware, consumables, validation support, and data management.

Moreover, companies that demonstrate robust quality management systems and transparent lot validation processes gain trust among laboratory directors and facility managers. Service-oriented firms differentiate through flexible contracting models, managed monitoring programs, and the ability to rapidly scale field operations for multi-site clients. From a commercial perspective, distribution strategies that combine direct engagement with channel partners and digital commerce facilitate faster deployment and localized support.

Intellectual property around assay chemistries and biosensor architectures continues to influence competitive positioning, and investments in regulatory submissions and field validation studies remain key barriers to entry. Firms that align R&D with pragmatic user needs-streamlined workflows, minimal training requirements, and clear interpretive guidance-are best positioned to win adoption among both centralized laboratories and decentralized facility teams. Ultimately, the market rewards combinations of technical excellence, operational support, and resilient supply chains.

Actionable strategic and operational measures that laboratory managers, procurement teams, and facility leaders can implement to enhance testing effectiveness and resilience

Industry leaders should adopt a multi-pronged strategy that balances investment in rapid diagnostics with rigorous validation and procurement resilience. First, prioritize validation studies that directly map test performance to operational decision thresholds, ensuring that chosen methods are fit-for-purpose across the specific sample matrices and use-case scenarios encountered in your facilities. Complement laboratory validation with field pilots that assess ease of use, maintenance demands, and downstream data integration requirements.

Second, strengthen supplier relationships by incorporating resilience criteria into procurement processes. Require transparency on reagent equivalence, alternate sourcing plans, and local technical support. Where feasible, diversify supplier portfolios to reduce exposure to single-source disruptions and evaluate long-term contracting to manage price volatility associated with policy shifts. Third, invest in workforce capability and procedural standardization so that test outputs reliably translate into corrective actions. Training programs, competency assessments, and clear escalation pathways will reduce interpretation variability and improve response times.

Finally, integrate testing outputs into broader water safety and facility management systems to turn data into preventive measures. Establish clear governance for data ownership, thresholds that trigger remediation, and periodic review processes that incorporate new scientific evidence and regulatory updates. By combining technical rigor with supply chain foresight and operational integration, organizations can enhance resilience and more effectively mitigate Legionella exposure risk.

Robust mixed-methods research approach combining stakeholder interviews, laboratory validation reviews, and supply chain mapping to inform pragmatic recommendations

The underlying research employs a mixed-methods approach designed to capture both technical performance attributes and operational realities. Primary research included structured interviews with laboratory directors, facility managers, water utility representatives, and regulatory stakeholders to gather qualitative insights on method preferences, procurement constraints, and validation expectations. These stakeholder perspectives were supplemented by observational reviews of laboratory workflows and field sampling protocols to ground conclusions in real-world practices.

Secondary research drew on peer-reviewed literature, regulatory guidance documents, and technical white papers to map method capabilities, performance characteristics, and compliance drivers. Laboratory verification studies were reviewed to evaluate comparative time-to-result, sensitivity, and operational requirements across culture, immunoassay, molecular, and biosensor approaches. Supply chain analyses assessed component sourcing pathways, distributor networks, and service model configurations to identify resilience factors and potential bottlenecks.

Analytic steps included cross-validation of qualitative findings with technical performance summaries and supply chain mapping, followed by synthesis into actionable recommendations. Where relevant, scenario analyses explored implications of procurement disruptions and regulatory shifts to inform strategic options without producing numeric forecasts. This methodology ensures that the findings reflect both the scientific realities of assay performance and the pragmatic constraints of implementation in diverse operational contexts.

Synthesis of key findings emphasizing how methodological rigor, procurement resilience, and operational integration translate diagnostics into effective exposure mitigation

In sum, the Legionella testing ecosystem is at an inflection point where technological capability, regulatory expectations, and procurement realities intersect. Advances in molecular diagnostics and biosensor platforms are delivering faster and more flexible options for detection, but their value hinges on rigorous validation, operational integration, and reliable supply chains. Tariff-related shifts have underscored the importance of supplier transparency and domestic resilience, influencing procurement strategies and prompting organizations to reassess inventory and sourcing policies.

Segmentation analysis clarifies that method selection must be purpose-driven: culture-based approaches remain central to many compliance frameworks, immunoassays and biosensors provide rapid screening capacity, and PCR techniques offer molecular sensitivity suited to specific investigative scenarios. Product choices, application contexts, end-user constraints, and distribution channels further determine feasibility and effectiveness. Region-specific dynamics add another layer of complexity, requiring adaptable offerings that respect regulatory diversity and technical capacity.

For leaders seeking to strengthen their Legionella programs, the path forward combines methodological rigor, resilient procurement, workforce capability, and data-driven governance. By aligning investments with operational needs and emphasizing validated equivalence and supplier continuity, organizations can translate diagnostic advances into sustained reductions in exposure risk and improved public health outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Expansion of remote IoT-enabled water monitoring systems for real-time Legionella detection in large facilities
  • 5.2. Adoption of digital PCR testing methods to improve sensitivity and speed in Legionella detection laboratories
  • 5.3. Integration of AI-driven predictive analytics for proactive Legionella risk assessment in building water systems
  • 5.4. Regulatory enforcement of mandatory routine Legionella testing under updated international water safety guidelines
  • 5.5. Development of portable rapid immunoassay devices for on-site Legionella screening to reduce laboratory dependence
  • 5.6. Implementation of centralized data platforms for multi-site Legionella testing results to facilitate compliance tracking
  • 5.7. Collaboration between water treatment firms and testing labs to deliver end-to-end Legionella management solutions

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Legionella Testing Market, by Test Method

  • 8.1. Biosensor
  • 8.2. Culture Method
    • 8.2.1. Membrane Filtration Culture
    • 8.2.2. Traditional Agar Culture
  • 8.3. Immunoassay
    • 8.3.1. Elisa
    • 8.3.2. Lateral Flow Assay
  • 8.4. Polymerase Chain Reaction
    • 8.4.1. Real-Time PCR
    • 8.4.2. Traditional PCR

9. Legionella Testing Market, by Product Type

  • 9.1. Equipment
    • 9.1.1. Automated Systems
    • 9.1.2. Manual Systems
  • 9.2. Kits
  • 9.3. Reagents And Consumables
    • 9.3.1. Antibodies
    • 9.3.2. Culture Media
    • 9.3.3. Dna Polymerases
  • 9.4. Services

10. Legionella Testing Market, by Application

  • 10.1. Environmental Monitoring
  • 10.2. Facility Management
  • 10.3. Water Treatment

11. Legionella Testing Market, by End User

  • 11.1. Commercial Buildings
  • 11.2. Hospitals
  • 11.3. Research Institutes
  • 11.4. Water Utilities

12. Legionella Testing Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
  • 12.3. Online

13. Legionella Testing Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Legionella Testing Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Legionella Testing Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Eurofins Scientific SE
    • 16.3.2. SGS SA
    • 16.3.3. ALS Limited
    • 16.3.4. Intertek Group plc
    • 16.3.5. Bureau Veritas SA
    • 16.3.6. TUV SUD AG
    • 16.3.7. NSF International
    • 16.3.8. Underwriters Laboratories LLC
    • 16.3.9. Pace Analytical Services, LLC
    • 16.3.10. Charles River Laboratories International, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL LEGIONELLA TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. LEGIONELLA TESTING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. LEGIONELLA TESTING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. LEGIONELLA TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL LEGIONELLA TESTING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL LEGIONELLA TESTING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY BIOSENSOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY BIOSENSOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY BIOSENSOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY BIOSENSOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY BIOSENSOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY BIOSENSOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY MEMBRANE FILTRATION CULTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY MEMBRANE FILTRATION CULTURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY MEMBRANE FILTRATION CULTURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY MEMBRANE FILTRATION CULTURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY MEMBRANE FILTRATION CULTURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY MEMBRANE FILTRATION CULTURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY TRADITIONAL AGAR CULTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY TRADITIONAL AGAR CULTURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY TRADITIONAL AGAR CULTURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY TRADITIONAL AGAR CULTURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY TRADITIONAL AGAR CULTURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY TRADITIONAL AGAR CULTURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ELISA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ELISA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ELISA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ELISA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REAL-TIME PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REAL-TIME PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REAL-TIME PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REAL-TIME PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY TRADITIONAL PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY TRADITIONAL PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY TRADITIONAL PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY TRADITIONAL PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY TRADITIONAL PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY TRADITIONAL PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY MANUAL SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY MANUAL SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY MANUAL SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY MANUAL SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY MANUAL SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY MANUAL SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ANTIBODIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ANTIBODIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ANTIBODIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ANTIBODIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ANTIBODIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY CULTURE MEDIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY CULTURE MEDIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY CULTURE MEDIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY CULTURE MEDIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY CULTURE MEDIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY CULTURE MEDIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DNA POLYMERASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DNA POLYMERASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DNA POLYMERASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DNA POLYMERASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DNA POLYMERASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DNA POLYMERASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY FACILITY MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY FACILITY MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY FACILITY MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY FACILITY MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY FACILITY MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY FACILITY MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY WATER TREATMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY WATER TREATMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY WATER TREATMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY WATER TREATMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY WATER TREATMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY WATER TREATMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY COMMERCIAL BUILDINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY COMMERCIAL BUILDINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY COMMERCIAL BUILDINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY COMMERCIAL BUILDINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY COMMERCIAL BUILDINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY COMMERCIAL BUILDINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY WATER UTILITIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY WATER UTILITIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY WATER UTILITIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY WATER UTILITIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY WATER UTILITIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY WATER UTILITIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ONLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ONLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ONLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY ONLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL LEGIONELLA TESTING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 240. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
  • TABLE 248. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2025-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2018-2024 (USD MILLION)
  • TABLE 250. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
  • TABLE 254. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2032 (USD MILLION)
  • TABLE 255. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 262. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 266. LATIN AMERICA LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPE LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPE LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPE LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPE LEGIONELLA TESTING MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPE LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPE LEGIONELLA TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPE LEGIONELLA TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPE LEGIONELLA TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPE LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPE LEGIONELLA TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 311. MIDDLE EAST LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 312. MIDDLE EAST LEGIONELLA TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 313. MIDDLE EAST LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
  • TABLE 314. MIDDLE EAST LEGIONELLA TESTING MARKET SIZE, BY TEST METHOD, 2025-2032 (USD MILLION)
  • TABLE 315. MIDDLE EAST LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2018-2024 (USD MILLION)
  • TABLE 316. MIDDLE EAST LEGIONELLA TESTING MARKET SIZE, BY CULTURE METHOD, 2025-2032 (USD MILLION)
  • TABLE 317. MIDDLE EAST LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
  • TABLE 318. MIDDLE EAST LEGIONELLA TESTING MARKET SIZE, BY IMMUNOASSAY, 2025-2032 (USD MILLION)
  • TABLE 319. MIDDLE EAST LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
  • TABLE 320. MIDDLE EAST LEGIONELLA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2032 (USD MILLION)
  • TABLE 321. MIDDLE EAST LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 322. MIDDLE EAST LEGIONELLA TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 323. MIDDLE EAST LEGIONELLA TESTING MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 324. MIDDLE EAST LEGIONELLA TE